人工臓器: 世界市場

出版：BCC Research（BCCリサーチ）　出版年月：2023年7月

Artificial Organs: Global Markets
人工臓器: 世界市場

レポート目次　　お問合せ・ご注文　　価格・納期について

Report Highlights

The global artificial organs market should reach $17.7 billion by 2028 from $14.4 billion in 2023 at a compound annual growth rate (CAGR) of 4.2% for the forecast period of 2023 to 2028.

Summary:

The increasing prevalence of organ failure, shortage of donor organs, technological advancements, and growing healthcare expenditure are the major factors driving the growth of this market.

The demand for organs is likely to rise in the future due to poor lifestyle habits such as excessive alcohol intake and smoking, which is leading to organ damage. The demand could also arise from accidents such as physical trauma. The general deterioration of organs with aging and wear and tear could give rise to a demand for organs in older people. Other reasons include –
– Chronic diabetes and infection or prolonged blood pressure lead to chronic kidney failure.
– Inheritance of liver disease, viral infection, autoimmune diseases, liver cancer, or other toxins. These diseases cause the liver cells to die and scar tissue to form, resulting in loss of function.
– Chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis, cystic fibrosis, or pulmonary hypertension gives rise to the demand for lung transplants.
– Diseases such as cardiomyopathy (where heart muscles are weakened or stiffened), myocarditis (inflammation of heart muscles), or coronary heart disease (blockages in blood vessels) could lead someone to require a heart transplant.

Growing awareness about the benefits of using artificial organs over traditional organ transplantation surgeries and an increase in R&D investments focused on developing new types of artificial organs is an additional factor propelling the growth of this market.

In 2022, the artificial kidney segment captured the highest share of the market, at about REDACTED%, followed by the artificial pancreas (REDACTED%), cochlear implant (REDACTED%), artificial heart (REDACTED%), and artificial lung (REDACTED%).

Report Scope:

This report is a comprehensive study of the global artificial organs market. It describes the artificial organs market, segmented by product type and region. Based on product type, the market is segmented into artificial hearts, artificial kidneys, artificial lungs, artificial pancreases, and cochlear implants. The market is segmented by region into North America, Latin America, Europe, Asia-Pacific, and the Rest of the World (RoW).

This report examines the factors driving growth in the artificial organ market, and it reviews major players, established companies, and new entrants.

This report, however, does not cover artificial limbs, artificial eyes, artificial intestines, artificial skin, or artificial blood vessels.

Report Synopsis

Report Includes:

– 28 data tables and 14 additional tables
– An overview of the global artificial organs market
– Analyses of global market trends, with data from 2020 to 2022, estimates for 2023 and projections of compound annual growth rates (CAGRs) through 2028
– Discussion about the benefits of using artificial organs over traditional organs in transplantation surgeries, and increase in development of new types of artificial organs as driving factors to the market
– Identification of challenges and discussion on how to overcome from those to reach its commercialization potential
– Insights into R&D investments, government growth-promoting policies, rules, and regulations
– Information on recent mergers, acquisitions, collaborations, agreements, partnerships, product launches, and expansions in the market and a relevant patent analysis
– Detailed company profiles of major players in the market, including Abbott, Getinge AB, LivaNova, Nipro Corp. and Sonova

目次

Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology
Information Sources
Primary Research
Secondary Research
Geographic Breakdown
Chapter 2 Summary and Highlights
Market Outlook
Highlights of the Artificial Organs Market
Chapter 3 Market Overview and Definitions
Overview
Artificial Organs
Chapter 4 Market Trends
Market Drivers
Aging Population
Diabetic Cases by Countries
Chronic Kidney Disease Cases by Countries
Penetration of Artificial Organs in Emerging Markets
Market Opportunity
Market Restraints
Chapter 5 Market Breakdown by Product Type
Introduction
Artificial Heart
Artificial Kidney
Artificial Lung
Artificial Pancreas
Cochlear Implant
Chapter 6 COVID-19 Impact Analysis
Introduction
COVID-19 Impact on the Medical Devices and Pharmaceutical Industries
Decline/Delay in Elective Procedures
Impact of COVID-19 on Medical Device and Pharmaceutical Product Segments
COVID-19 Impact on Artificial Organs Markets
Chapter 7 Market Breakdown by Region
Market Overview and Discussion
North America
U.S.
Canada
Mexico
Latin America
Brazil
Argentina
Chile
Europe
Germany
France
U.K.
Spain
Italy
Rest of Europe
Asia-Pacific
China
India
Japan
Rest of Asia-Pacific
Rest of the World
Chapter 8 Competitive Landscape
Industry Scenario
Company Shares
Chapter 9 Emerging/Upcoming Technologies
Key/Emerging Technologies/Trends in the Market
Tissue Engineering and Regenerative Medicine
Organ-on-a-Chip
Bio-fabrication and 3D Bioprinting
Biomaterials and Biocompatible Materials
Immunomodulation and Immunotolerance Strategies
Neural Interfaces and Brain-Machine Interfaces
Gene Editing and Gene Therapy
Chapter 10 M&A and Fundings Outlook
M&A Analysis
SynCardia System’s Acquisition by Versa Capital Management
Abiomed’s Acquisition of Berlin Heart
LivaNova’s Acquisition of TandemLife
Fresenius Medical Care’s Acquisition of NxStage Medical
B. Braun’s Acquisition of NxStage Medical’s Bloodlines Business
LivaNova’s Acquisition of TandemLife
Cantel Medical’s Acquisition of hemodialysis business from Gambro
Eli Lilly’s Acquisition of Protomer Technologies
Johnson & Johnson Acquisition of Abiomed Inc.
Chapter 11 Sustainability in Artificial Organs Market: An ESG Perspective
Introduction
Environmental Factors
Social Factors
Governance Factors
Artificial Organs Market: ESG Performance Analysis, by Company
Conclusion
Chapter 12 Patent Analysis
Patent Analysis by Manufacturer
Chapter 13 Pipeline Analysis
Clinical Trials Scenario
Chapter 14 Company Profiles
ABIOMED
ABBOTT
BAXTER INTERNATIONAL INC.
B. BRAUN SE
COCHLEAR LTD.
FRESENIUS MEDICAL CARE AG & CO. KGAA
F. HOFFMANN-LA ROCHE AG
GETINGE AB
INSULET CORP.
LIVANOVA PLC
MEDTRONIC
MED-EL MEDICAL ELECTRONICS
NIPRO CORP.
SONOVA
TERUMO CORP.
TANDEM DIABETES CARE, INC.
YPSOMED AG

List of Tables
Summary Table : Global Market for Artificial Organs, by Product Type, Through 2028
Table 1 : Global Population, Aged 60 and Older, 2010-2050
Table 2 : Diabetic Cases, by Country, 2000-2045
Table 3 : Chronic Kidney Disease Cases, by Country, 2017-2023
Table 4 : Global Market for Artificial Organs, by Product Type, Through 2028
Table 5 : Global Market for Artificial Hearts, by Region, Through 2028
Table 6 : Global Market for Artificial Kidneys, by Region, Through 2028
Table 7 : Global Market for Artificial Lungs, by Region, Through 2028
Table 8 : Global Market for Artificial Pancreases, by Region, Through 2028
Table 9 : Global Market for Cochlear Implants, by Region, Through 2028
Table 10 : Global Market for Artificial Organs, by Region, Through 2028
Table 11 : North American Market for Artificial Organs, by Country, Through 2028
Table 12 : Latin American Market for Artificial Organs, by Country, Through 2028
Table 13 : European Market for Artificial Organs, by Country, Through 2028
Table 14 : Asia-Pacific Market for Artificial Organs, by Country, Through 2028
Table 15 : RoW Market for Artificial Organs, Through 2028
Table 16 : Medtronic ESG Performance
Table 17 : Abbott ESG Performance
Table 18 : Cochlear Ltd. ESG Performance
Table 19 : Artificial Heart Patents, by Organization, 2019-2022
Table 20 : Artificial Kidney Patents, by Organization, 2019-2022
Table 21 : Artificial Lung Patents, by Organization, 2019-2022
Table 22 : Artificial Pancreas, by Organization, 2019-2022
Table 23 : Cochlear Implants, by Organization, 2019-2022
Table 24 : Selected Artificial Heart Devices in Clinical Trials, 2023
Table 25 : Selected Artificial Kidney Devices in Clinical Trials, 2023
Table 26 : Selected Artificial Lung Devices in Clinical Trials, 2023
Table 27 : Selected Artificial Pancreas in Clinical Trials, 2023
Table 28 : Selected Cochlear Implants in Clinical Trials, as of 2023
Table 29 : Abbott: Revenue, by Segment, 2020-2022
Table 30 : Abbott: Revenue, by Region, 2020-2022
Table 31 : Baxter International Inc.: Revenue, by Segment, 2020-2022
Table 32 : Baxter International Inc.: Revenue, by Region, 2021 and 2022
Table 33 : F. Hoffmann-La Roche Ltd.: Financials, 2020-2022
Table 34 : F. Hoffmann-La Roche Ltd.: Revenue, by Diagnostic Segment, 2020-2022
Table 35 : Getinge AB: Revenue, by Segment, 2020-2022
Table 36 : Insulet Corp.: Revenue, by Segment, 2020-2022
Table 37 : LivaNova: Revenue, by Segment, 2020-2022
Table 38 : Nipro Corp.: Revenue, by Segment, 2020-2022
Table 39 : Sonova: Revenue, by Segment, 2021 and 2022
Table 40 : Sonova: Revenue, by Region, 2021 and 2022
Table 41 : Acronyms Used in This Report

List of Figures
Summary Figure A : Global Market for Artificial Organs, by Product Type, 2020-2028
Summary Figure B : Global Market Shares of Artificial Organs, by Product Type, 2022
Figure 1 : Global Market for Artificial Organs, by Product, 2020-2028
Figure 2 : Global Market Shares of Artificial Organs, by Product, 2022
Figure 3 : Global Market for Artificial Hearts, by Region, 2020-2028
Figure 4 : Global Market Shares of Artificial Hearts, by Region, 2022
Figure 5 : Global Market for Artificial Kidneys, by Region, 2020-2028
Figure 6 : Global Market Shares of Artificial Kidneys, by Region, 2022
Figure 7 : Global Market for Artificial Lungs, by Region, 2020-2028
Figure 8 : Global Market Shares of Artificial Lungs, by Region, 2022
Figure 9 : Global Market for Artificial Pancreases, by Region, 2020-2028
Figure 10 : Global Market Shares of Artificial Pancreases, by Region, 2022
Figure 11 : Global Market for Cochlear Implants, by Region, 2020-2028
Figure 12 : Global Market Shares of Cochlear Implants, by Region, 2022
Figure 13 : Global Market Shares of Artificial Organs, by Region, 2022
Figure 14 : North American Market Shares of Artificial Organs, by Country, 2022
Figure 15 : Latin American Market Shares of Artificial Organs, by Country, 2022
Figure 16 : European Market Shares of Artificial Organs, by Country, 2022
Figure 17 : Asia-Pacific Market Shares of Artificial Organs, by Country, 2022
Figure 18 : Global Market Shares of Artificial Organs, by Company, 2022
Figure 19 : Global Market Shares of Artificial Heart, by Company, 2022
Figure 20 : Global Market Shares of Artificial Kidney, by Company, 2022
Figure 21 : Global Market Shares of Artificial Lung, by Company, 2022
Figure 22 : Global Market Shares of Artificial Pancreas, by Company, 2022
Figure 23 : Global Market Shares of Cochlear Implants, by Company, 2022
Figure 24 : Emerging Trends/Technologies in the Artificial Organs Market
Figure 25 : Abiomed: Company Revenue, 2020-2022
Figure 26 : Abbott: Company Revenue, 2020-2022
Figure 27 : Abbott: Revenue Share, by Segment, 2022
Figure 28 : Abbott: Revenue Share, by Region
Figure 29 : Baxter International Inc.: Company Revenue, 2020-2022
Figure 30 : Baxter International Inc.: Revenue Share, by Segment, 2022
Figure 31 : B. Braun: Company Revenue, 2020-2022
Figure 32 : Cochlear: Implant Sales, 2020-2022
Figure 33 : Fresenius Medical Care: Revenue, 2020-2022
Figure 34 : Getinge AB: Company Revenue, 2020-2022
Figure 35 : Insulet Corp.: Company Revenue, 2020-2022
Figure 36 : LivaNova: Company Revenue, 2020-2022
Figure 37 : Medtronic: Company Revenue, 2020-2022
Figure 38 : Nipro Corp.: Company Revenue, 2020-2022
Figure 39 : Nipro Corp.: Revenue Share, by Segment, 2022
Figure 40 : Nipro Corp.: Revenue Share, by Region/Country, 2022
Figure 41 : Sonova: Company Revenue, 2021 and 2022
Figure 42 : Sonova: Revenue Share, by Segment, 2022
Figure 43 : Sonova: Revenue Share, by Region, 2022
Figure 44 : Tandem Diabetes Care: Company Revenue, 2020-2022
Figure 45 : Ypsomed: Company Revenue, 2020-2022